IL-22 deficiency increases CD4 T cell responses to mucosal immunization. (Q54217819)

26 May 2018

title

IL-22 deficiency increases CD4 T cell responses to mucosal immunization. (English)

1 reference

26 May 2018

0 references

Scott A Budda

1

1 reference

26 May 2018

Lauren A Zenewicz

series ordinal

2

1 reference

26 May 2018

language of work or name

English

0 references

publication date

5 May 2018

1 reference

26 May 2018

published in

Vaccine

1 reference

26 May 2018

Compartmentalization of the mucosal immune responses to commensal intestinal bacteria

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

The anatomy of mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Overview of gut immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Mucosal vaccines: the promise and the challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Recent progress in mucosal vaccine development: potential and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22: immunobiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Therapeutic opportunities of the IL-22-IL-22R1 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 increases the innate immunity of tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-23R innate lymphoid cells induce colitis via interleukin-22-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Designing tomorrow's vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Antimicrobial defense of the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 dampens the T cell response in experimental malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

CD4 T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2018.05.011

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

7 January 2021

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI33194

Identifiers

DOI

10.1016/J.VACCINE.2018.05.011

1 reference

26 May 2018

1 reference

26 May 2018